We are torn between grooming our current Integrator to buy us out and launching an open-market sale with an investment banker. How do we objectively evaluate these options without stalling our operational momentum?

Question

Tyler Smith · Accepted Answer

Choosing between an internal successor and an external market sale is not a matter of sentiment. It is a financial and operational calculation. You must evaluate this choice by comparing the net proceeds, transition terms, and execution risk of both paths.

An internal transition to your current Integrator typically offers a higher probability of cultural preservation and a smoother transition. However, internal buyers rarely have the capital to buy you out cash on hand, meaning you will likely have to finance a portion of the transaction through a seller note or retain equity. You must ask whether your Integrator truly has the GWC to run the company without you, and whether you are willing to tie your financial freedom to their future performance.

An external sale through an investment banker usually yields a higher valuation multiple and more cash at close. The trade-off is intense due diligence, cultural disruption, and the likelihood of a grueling transition period.

To make this decision without stalling your momentum, use your quarterly V/TO review to isolate the decision. Keep the evaluation confined to the ownership level, keeping the operational leadership team focused on their weekly Rocks and Level 10 Meetings. Do not let the debate bleed into daily operations. If you decide on an external sale, run a clean process with a banker. If you choose the internal route, begin structuring the buy-sell agreements immediately so the transition timeline is clear and legally binding.